Antibiotic resistance is a growing public health concern, as bacteria develop resistance to commonly used antibiotics, making infections more difficult to treat and potentially leading to increased morbidity and mortality. The antibiotic resistance market includes a range of pharmaceutical and diagnostic products, as well as research and development efforts aimed at developing new antibiotics and combating resistance.
Worldwide revenue from the antibiotic resistance market stands at US$ 10.1 Billion in 2022, with the global market estimated to surge ahead at a CAGR value of 5.3% to reach a valuation of US$ 17.8 Billion by the end of 2033.
Leading Players are:
- Thermo Fisher Scientific, Inc
- Merck KgaA
- Bio-Rad Laboratories, Inc.
- Takara Bio, Inc.
- QIAGEN N.V.
- Pall Corporation
- Eppendorf Corporate
- Tarsons Products PVT. LTD.
- Applied Biological Materials Inc.
Get a Free PDF Sample of this Report Here:
One of the key drivers of the market is the increasing prevalence of antibiotic-resistant infections. The World Health Organization has identified antibiotic resistance as one of the greatest threats to global health, and estimates that at least 700,000 people die each year as a result of drug-resistant infections. As bacteria continue to evolve and develop resistance to existing antibiotics, there is an urgent need for new treatment options.
Another factor driving growth in the antibiotic resistance market is the increasing investment in research and development. Governments and private companies around the world are investing heavily in efforts to develop new antibiotics and combat resistance, including initiatives such as the Antibiotic Resistance Action Center at George Washington University and the UK government’s 20-year strategy to tackle antimicrobial resistance.
However, the antibiotic resistance market is not without its challenges. One of the main obstacles is the high cost of research and development for new antibiotics. Developing a new antibiotic can take years and cost hundreds of millions of dollars, and many pharmaceutical companies are hesitant to invest in a market that may not be profitable.
You Can Purchase this Report as per Your Interest Click Here:
Overall, the antibiotic resistance market is expected to continue to grow in the coming years, driven by a combination of factors such as increasing prevalence of resistance, growing investment in research and development, and regulatory support for new therapies. However, companies in the industry will need to navigate a range of challenges, including the need for continued investment in research and development, the regulatory hurdles associated with bringing new antibiotics to market, and the need for increased awareness and action to combat antibiotic resistance.
Check out more Premium studies published by Persistence Market Research
|Life Sciences Aggregate-Spending Market|
|Europe Cryochambers Market|
|Clostridium Difficile Infection Treatment Market|
|Airway Clearance System Market|
|Effervescent Products Market|
About Persistence Market Research:
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – firstname.lastname@example.org